دوره 14، شماره 1 - ( 1403 )                   جلد 14 شماره 1 صفحات 71-64 | برگشت به فهرست نسخه ها


XML Print


Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:

Pazyar N, Kheirkhah N, Yaghoobi R, Bakhtiari N. Enhancing Repigmentation in Vitiligo: A Comparative Clinical Trial of Microneedling with Topical 5-Fluorouracil, Fluocinolone, and Microneedling Alone. WJPS 2025; 14 (1) :64-71
URL: http://wjps.ir/article-1-1390-fa.html
Enhancing Repigmentation in Vitiligo: A Comparative Clinical Trial of Microneedling with Topical 5-Fluorouracil, Fluocinolone, and Microneedling Alone. مجله جهانی جراحی پلاستیک. 1403; 14 (1) :64-71

URL: http://wjps.ir/article-1-1390-fa.html


چکیده:   (313 مشاهده)
Background: Vitiligo, a pigmentary skin disorder, poses therapeutic challenges due to its progressive nature and varied treatment responses. We aimed to investigate the efficacy of a novel approach, combining microneedling with topical 5-Fluorouracil (5-FU), compared with microneedling with Fluocinolone and microneedling alone for treating vitiligo lesions.
Methods: A single-blinded clinical trial was conducted from Aug 2022 to Feb 2023 at Ahvaz University of Medical Sciences, Ahvaz, Iran. Twenty patients with persistent vitiligo lesions were randomly assigned to three treatment groups. Microneedling was performed using Dermapen cartridge 36 once a week for 12 wk. In patch A, 5% 5-FU cream was applied immediately after microneedling; in patch B, patients used fluocinolone 0.025% cream twice daily; and in patch C, microneedling was performed alone. Clinical repigmentation was evaluated using the G-score scale, and treatment side effects were recorded.
Results: Microneedling combined with 5-FU demonstrated significantly higher repigmentation rates, with 70% of lesions showing moderate to excellent responses (P<0.001). In contrast, microneedling with Fluocinolone and microneedling alone exhibited lower response frequencies. Side effects were minimal, with only one patient experiencing burning and itching in the microneedling and 5-FU group. No corticosteroid-related complications were observed. Six months follow-up revealed sustained repigmentation in the microneedling and 5-FU group, contrasting with no response or recurrence in microneedling alone-treated lesions.
Conclusion: Microneedling combined with topical 5-FU presents a promising therapeutic strategy for vitiligo lesions, yielding superior repigmentation outcomes compared to other treatments.
 
     
نوع مطالعه: مقالات اصيل | موضوع مقاله: تخصصي
انتشار الکترونیک: 1404/1/16

فهرست منابع
1. Ortonne J-P. Vitiligo and other hypomelanoses of hair and skin: Springer Science & Business Media; 2012.
2. Bergqvist C, Ezzedine K. Vitiligo: A Review. Dermatology 2020;236(6):571-92. [DOI:10.1159/000506103]
3. Henning SW, Jaishankar D, Barse LW, et al. The relationship between stress and vitiligo: Evaluating perceived stress and electronic medical record data. PLoS One 2020;15(1):e0227909. [DOI:10.1371/journal.pone.0227909]
4. de Baat C, Phoa KH, Zweers P, Bolling MC, Rozema FR, Vissink A. [Medicaments and oral healthcare. Hyperpigmentation of oral soft tissues due to afamelanotide]. Ned Tijdschr Tandheelkd 2020 Apr;127(4):237-43. [DOI:10.5177/ntvt.2020.04.19115]
5. Ahmed Jan N, Masood S. Vitiligo. StatPearls. Treasure Island (FL): StatPearls PublishingCopyright © 2023, StatPearls Publishing LLC.; 2023.
6. Gauthier Y, Anbar T, Lepreux S, Cario-André M, Benzekri L. Possible mechanisms by which topical 5-fluorouracil and dermabrasion could induce pigment spread in vitiligo skin: an experimental study. International Scholarly Research Notices 2013;2013. [DOI:10.1155/2013/852497]
7. Anbar TS, Westerhof W, Abdel-Rahman AT, Ewis AA, El-Khayyat MA. Effect of one session of ER:YAG laser ablation plus topical 5Fluorouracil on the outcome of short-term NB-UVB phototherapy in the treatment of non-segmental vitiligo: a left-right comparative study. Photodermatol Photoimmunol Photomed 2008 Dec;24(6):322-9. [DOI:10.1111/j.1600-0781.2008.00385.x]
8. Sethi S, Mahajan BB, Gupta RR, Ohri A. Comparative evaluation of the therapeutic efficacy of dermabrasion, dermabrasion combined with topical 5% 5-fluorouracil cream, and dermabrasion combined with topical placentrex gel in localized stable vitiligo. Int J Dermatol 2007 Aug;46(8):875-9. [DOI:10.1111/j.1365-4632.2007.03226.x]
9. Borderé AC, Lambert J, van Geel N. Current and emerging therapy for the management of vitiligo. Clin Cosmet Investig Dermatol 2009 Mar 12;2:15-25. [DOI:10.2147/CCID.S3627]
10. Pazyar N, Hatami M, Yaghoobi R, Parvar SY, Radmanesh M, Hadibarhaghtalab M. The efficacy of adding topical 5-fluorouracil to micro-needling in the treatment of vitiligo: A randomized controlled trial. J Cosmet Dermatol 2023;22(5):1513-20. [DOI:10.1111/jocd.15616]
11. Singh A, Yadav S. Microneedling: Advances and widening horizons. Indian Dermatol Online J 2016 Jul-Aug;7(4):244-54. [DOI:10.4103/2229-5178.185468]
12. Orentreich DS, Orentreich N. Subcutaneous incisionless (subcision) surgery for the correction of depressed scars and wrinkles. Dermatol Surg 1995 Jun;21(6):543-9. [DOI:10.1111/j.1524-4725.1995.tb00259.x]
13. Mina M, Elgarhy L, Al‐saeid H, Ibrahim Z. Comparison between the efficacy of microneedling combined with 5‐fluorouracil vs microneedling with tacrolimus in the treatment of vitiligo. J Cosmet Dermatol 2018;17(5):744-51. [DOI:10.1111/jocd.12440]
14. Attwa EM, Khashaba SA, Ezzat NA. Evaluation of the additional effect of topical 5‐fluorouracil to needling in the treatment of localized vitiligo. J Cosmet Dermatol 2020;19(6):1473-8. [DOI:10.1111/jocd.13152]
15. El-Fakahany H, Raouf HA, Medhat W. Automated microneedling and topical 5-flurouracil solution may help in treating acral vitiligo. Journal of the American Academy of Dermatology; 2016: Mosby-Elsevier 360 park avenue south, new york, NY 10010-1710 USA; 2016. p. AB231-AB. [DOI:10.1016/j.jaad.2016.02.909]

ارسال نظر درباره این مقاله : نام کاربری یا پست الکترونیک شما:
CAPTCHA

بازنشر اطلاعات
Creative Commons License این مقاله تحت شرایط Creative Commons Attribution-NonCommercial 4.0 International License قابل بازنشر است.

کلیه حقوق این وب سایت متعلق به مجله جهانی جراحی پلاستیک می باشد.

طراحی و برنامه نویسی : یکتاوب افزار شرق

© 2025 CC BY-NC 4.0 | World Journal of Plastic Surgery

Designed & Developed by : Yektaweb